The Effect of Femoral Nerve Block on Postoperative Opioid Use After Anterior Cruciate Ligament (ACL) Reconstruction
Phase 1
- Conditions
- Pain, Postoperative
- Registration Number
- NCT00175630
- Lead Sponsor
- University of British Columbia
- Brief Summary
This study evaluates the effect of a femoral nerve block on opioid requirements following anterior cruciate ligament (ACL) reconstruction. This is a double blind, prospective randomized controlled trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Schedule for primary elective anterior cruciate ligament reconstruction
- Tolerance to bupivacaine
- Tolerance to non-steroidal anti-inflammatory drugs (NSAIDs)
- Informed consent
Exclusion Criteria
- Patients who received a femoral nerve block more than 1 hour prior to surgery
- Complex associated injuries or pre-existing conditions that will delay time to ambulation
- Children with tibial avulsion fractures
- Allergic and/or sensitive to bupivacaine and/or NSAIDs
- 30% over ideal body weight
- Acute ACL reconstruction (done less than 2 weeks after injury)
- Pre-existing femoral nerve injury
- Psychiatric patients on psychotropic agents
- History of drug or alcohol dependence or recreational drug use
- Refusal to provide informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Postoperative morphine requirement
- Secondary Outcome Measures
Name Time Method Pain rating immediately post-op Opioid surgical time time from end of anaesthesia to first requirement of morphine
Trial Locations
- Locations (1)
British Columbia Children's Hospital, Department of Orthopaedics
🇨🇦Vancouver, British Columbia, Canada